215 related articles for article (PubMed ID: 27374176)
1. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
[TBL] [Abstract][Full Text] [Related]
2. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
Li K; Zhang H; Qiu J; Lin Y; Liang J; Xiao X; Fu L; Wang F; Cai J; Tan Y; Zhu W; Yin W; Lu B; Xing F; Tang L; Yan M; Mai J; Li Y; Chen W; Qiu P; Su X; Gao G; Tai PW; Hu J; Yan G
Mol Ther; 2016 Feb; 24(1):156-65. PubMed ID: 26373347
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
Lin Y; Zhang H; Liang J; Li K; Zhu W; Fu L; Wang F; Zheng X; Shi H; Wu S; Xiao X; Chen L; Tang L; Yan M; Yang X; Tan Y; Qiu P; Huang Y; Yin W; Su X; Hu H; Hu J; Yan G
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4504-12. PubMed ID: 25288727
[TBL] [Abstract][Full Text] [Related]
4. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Xiao X; Liang J; Huang C; Li K; Xing F; Zhu W; Lin Z; Xu W; Wu G; Zhang J; Lin X; Tan Y; Cai J; Hu J; Chen X; Huang Y; Qin Z; Qiu P; Su X; Chen L; Lin Y; Zhang H; Yan G
Nat Commun; 2018 Oct; 9(1):4342. PubMed ID: 30337542
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
6. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
[TBL] [Abstract][Full Text] [Related]
8. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
Cai J; Lin Y; Zhang H; Liang J; Tan Y; Cavenee WK; Yan G
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6812-6817. PubMed ID: 28607091
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM
Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948
[TBL] [Abstract][Full Text] [Related]
10. Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
Choi EJ; Ren Y; Chen Y; Liu S; Wu W; Ren J; Wang P; Garofalo RP; Zhou J; Bao X
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185593
[TBL] [Abstract][Full Text] [Related]
11. Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death.
Mahoney DJ; Lefebvre C; Allan K; Brun J; Sanaei CA; Baird S; Pearce N; Grönberg S; Wilson B; Prakesh M; Aman A; Isaac M; Mamai A; Uehling D; Al-Awar R; Falls T; Alain T; Stojdl DF
Cancer Cell; 2011 Oct; 20(4):443-56. PubMed ID: 22014571
[TBL] [Abstract][Full Text] [Related]
12. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Cai J; Lin K; Cai W; Lin Y; Liu X; Guo L; Zhang J; Xu W; Lin Z; Wong CW; Sander M; Hu J; Yan G; Zhu W; Liang J
Mol Oncol; 2020 Dec; 14(12):3153-3168. PubMed ID: 33037696
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease.
Oldenburger A; Roscioni SS; Jansen E; Menzen MH; Halayko AJ; Timens W; Meurs H; Maarsingh H; Schmidt M
PLoS One; 2012; 7(2):e31574. PubMed ID: 22363678
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
15. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
[TBL] [Abstract][Full Text] [Related]
16. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
Juhász T; Matta C; Somogyi C; Katona É; Takács R; Soha RF; Szabó IA; Cserháti C; Sződy R; Karácsonyi Z; Bakó E; Gergely P; Zákány R
Cell Signal; 2014 Mar; 26(3):468-82. PubMed ID: 24333667
[TBL] [Abstract][Full Text] [Related]
17. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
[TBL] [Abstract][Full Text] [Related]
18. H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition.
Inoue H; Hase K; Segawa A; Takita T
Eur J Pharmacol; 2013 Aug; 714(1-3):170-7. PubMed ID: 23810683
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
Yu M; Liu T; Chen Y; Li Y; Li W
J Exp Clin Cancer Res; 2018 Jun; 37(1):114. PubMed ID: 29866132
[TBL] [Abstract][Full Text] [Related]
20. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer.
Sun S; Liu Y; He C; Hu W; Liu W; Huang X; Wu J; Xie F; Chen C; Wang J; Lin Y; Zhu W; Yan G; Cai J; Li S
Cancer Lett; 2021 Apr; 502():9-24. PubMed ID: 33444691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
